Events

How Picture Description Tasks Can Help Track Cognitive Health Remotely

How Picture Description Tasks Can Help Track Cognitive Health Remotely Speech as a digital biomarker in clinical research Changes in how we speak—how quickly we talk, how often we pause, and the words we choose—can be early signs of cognitive decline. People with mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) often […]

How Picture Description Tasks Can Help Track Cognitive Health Remotely Read More »

Cognition in The Blood (Biomarker)

Cognition in The Blood (Biomarker) How do digital cognitive assessments relate to the Blood Plasma p-Tau217 in patients with Mild Cognitive Impairment (MCI)? Our latest research explores an exciting dataset with the AI–Mind Project, who have given us the opportunity to test the associations of our cognitive assessments alongside classic paper-and-pencil tests to levels of

Cognition in The Blood (Biomarker) Read More »

Actigraphy and wearable sensor technologies to enhance assessment in health conditions

Actigraphy and wearable sensor technologies to enhance assessment in health conditions affecting motor function and behaviour Reflections from the 2025 Actigraph Digital Data Summit​ The 2025 ActiGraph Digital Data Summit in Pensacola, FL, provided a valuable environment for exploring the benefits and challenges of using actigraphy, and other wearable sensor technologies, to enhance assessment in

Actigraphy and wearable sensor technologies to enhance assessment in health conditions Read More »

ISCTM 2025

ISCTM | 21st Annual Scientific Meeting Washington, D.C., USA | 19-21 February 2025 About the ISCTM The International Society for CNS Clinical Trials and Methodology (ISCTM) is an independent multi-disciplinary organization devoted to promoting advances in, and dissemination of, clinical research methods related to development and use of CNS therapeutics. The ISCTM accomplishes this by

ISCTM 2025 Read More »

Exploring Innovation in Alzheimer’s Disease Research: Highlights from CTAD 2024

Exploring Innovation in Alzheimer’s Disease Research Highlights from CTAD 2024 17th Clinical Trials on Alzheimer’s Disease (CTAD) Madrid (Spain) October 29 – November 1, 2024 Last week, our team travelled to Madrid to participate in the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference, where we had the opportunity to present our latest research and

Exploring Innovation in Alzheimer’s Disease Research: Highlights from CTAD 2024 Read More »

Shaping the Future of Patient-Centric, AI-Driven Research

Highlights from the Clinical Trials Innovation Summit 2024 San Francisco, CA – 22nd October 2024 The 2024 Clinical Trials Innovation Summit, hosted by Genentech in San Francisco, gathered experts from across the clinical trial field to reimagine patient care through AI-driven innovation. Featuring industry leaders, clinicians, and researchers this event explored how technological advances and

Shaping the Future of Patient-Centric, AI-Driven Research Read More »

Scroll to Top